Table of Contents
A preterm or premature baby is born before the 37th or 40th week of gestation. Premature infants are usually very tiny and have lower total blood volumes. However, preterm delivery stem cell collection is still highly viable in such cases. Clinical evidence suggests that while preterm babies are born with underdeveloped organs and depend on the NICU for breathing, feeding, and temperature regulation, the cellular density in preterm blood is often remarkable. This article highlights how the relation between gestational age and concentration of stem cells is proportionate, and that the concentration of stem cells is quite rich, even though the collection volume is 40% lower compared to full-term babies.
Impact on Cord Blood Volume and Cell Count
The volume and quality of cord blood increase steadily as the pregnancy reaches its end. Premature babies miss out on this support. Consequently, full-term births often yield a higher total volume of blood for collection. However, preterm labour and stem cell banking must not be taken lightly as the concentration of stem cells within that blood tells a different story. Research indicates that preterm cord blood is often exceptionally rich in CD34+ cells vital for engraftment and provides an ideal genetic match for potential regenerative therapies.
Volume is a major factor in the success of cord blood banking. A larger volume usually contains a higher Total Nucleated Cell (TNC) count. Preterm infants, especially those born before 32 weeks, have smaller placentas and cords. This naturally results in a lower total volume of blood during collection. In some cases, the volume may fall below the minimum processing threshold.
Delayed Cord Clamping in Preterm Deliveries
Most neonatologists prioritise the immediate health benefits of delayed cord clamping for preterm deliveries. This practice is beneficial for the transfer of blood from the placenta to the infant, preventing the risk of intraventricular haemorrhage. It also supports better circulatory stability during the first critical hours of life. However, delayed cord clamping inherently reduces the amount of blood left for banking purposes. This creates a clinical dilemma for parents who wish to pursue both.
Successful cord blood collection in a premature baby is still possible after delayed cord clamping. It only requires trained professionals, specialised collection kits and choosing futuristic laboratories fitted with advanced equipment to extract maximum stem cells from even a lower volume of cord blood sample.
Cord Tissue Banking
Alongside the physical size of preterm babies, the blood volume is lower when compared to that of full-term babies. The scanty cord blood volume can be compensated for by means of cord tissue banking. This process involves storing sections of the umbilical cord itself rather than blood. In case of stem cell banking in preterm delivery, cord tissue enriched with Mesenchymal Stem Cells can be collected for successful storage. For a preterm child, Mesenchymal Stem Cells could eventually treat complications related to lung or brain development.
Laboratory Processing and Accreditation Standards
The process of cord blood banking requires cord blood banks to handle low-volume samples with extreme care to avoid any cell loss. Choosing a bank with international accreditation that follows stringent protocols is particularly important. These standards ensure that the sample remains viable for many decades of storage.
Expectant parents who ask themselves if stem cell collection is possible in preterm birth should inquire about the cord blood bank’s experience with preterm or low-volume collections. Proprietary technology enhances the recovery of cells from small samples. The quality of the cryopreservation process is also vital for long-term cell health. Samples are stored at extremely low temperatures to halt all biological ageing processes. This preserves the pristine and active nature of the preterm stem cells.
Clinical Outlook for Preterm Stem Cell Applications
The future of stem cell therapy is promising for preterm infants. Research shows that Mesenchymal Stem Cells are extremely potent in treating bronchopulmonary dysplasia, a chronic lung disease common in premature babies. Other studies have found that stem cell transplantation can streamline treatment for neonatal brain injuries. These neuroprotective therapies could significantly improve long-term developmental outcomes for the child.
As regenerative medicine advances, the value of stored stem cells can only grow exponentially. The cells collected today are a bridge to the medical breakthroughs of tomorrow. Every preterm birth is a unique experience that requires a tailored plan. With the right information, parents can make a confident and informed decision.
Conclusion
Preterm delivery does affect the parameters of stem cell collection, but it does not prevent it. While blood volumes may be lower, the cellular quality often remains exceptionally high. Through a combination of blood and tissue banking, families can overcome volume limitations. The decision to bank premature cord blood stem cells is a proactive investment in a child’s health.